MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
*Portfolio Companies: Eli Lilly
CoLucid Pharmaceuticals (NASDAQ:CLCD)
Organization & Developments: CoLucid Pharmaceuticals
Parents
CoLucid Pharmaceuticals (NASDAQ:CLCD)
Children
2016: This stock more than doubled in trading Tuesday after the company disclosed very positive Phase III data for its compound lasmiditan to treat migraines.
CoLucid is leading a paradigm shift in migraine therapy with the clinical development of a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA).
Developing innovative therapies to treat CNS disorders
Jumps
*Key People: CoLucid Pharmaceuticals
Finance & Acquisition: CoLucid Pharmaceuticals